Gut microbiota signatures in inflammatory bowel disease

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Gut microbiota signatures in inflammatory bowel disease. / Vestergaard, Marie Vibeke; Allin, Kristine H.; Eriksen, Carsten; Zakerska-Banaszak, Oliwia; Arasaradnam, Ramesh P.; Alam, Mohammad T.; Kristiansen, Karsten; Brix, Susanne; Jess, Tine.

I: United European Gastroenterology Journal, Bind 12, Nr. 1, 2024, s. 22-33.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Vestergaard, MV, Allin, KH, Eriksen, C, Zakerska-Banaszak, O, Arasaradnam, RP, Alam, MT, Kristiansen, K, Brix, S & Jess, T 2024, 'Gut microbiota signatures in inflammatory bowel disease', United European Gastroenterology Journal, bind 12, nr. 1, s. 22-33. https://doi.org/10.1002/ueg2.12485

APA

Vestergaard, M. V., Allin, K. H., Eriksen, C., Zakerska-Banaszak, O., Arasaradnam, R. P., Alam, M. T., Kristiansen, K., Brix, S., & Jess, T. (2024). Gut microbiota signatures in inflammatory bowel disease. United European Gastroenterology Journal, 12(1), 22-33. https://doi.org/10.1002/ueg2.12485

Vancouver

Vestergaard MV, Allin KH, Eriksen C, Zakerska-Banaszak O, Arasaradnam RP, Alam MT o.a. Gut microbiota signatures in inflammatory bowel disease. United European Gastroenterology Journal. 2024;12(1):22-33. https://doi.org/10.1002/ueg2.12485

Author

Vestergaard, Marie Vibeke ; Allin, Kristine H. ; Eriksen, Carsten ; Zakerska-Banaszak, Oliwia ; Arasaradnam, Ramesh P. ; Alam, Mohammad T. ; Kristiansen, Karsten ; Brix, Susanne ; Jess, Tine. / Gut microbiota signatures in inflammatory bowel disease. I: United European Gastroenterology Journal. 2024 ; Bind 12, Nr. 1. s. 22-33.

Bibtex

@article{20c4da27aaa84431aa077a9cd3a4aad7,
title = "Gut microbiota signatures in inflammatory bowel disease",
abstract = "Background: Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), affect millions of people worldwide with increasing incidence. Objectives: Several studies have shown a link between gut microbiota composition and IBD, but results are often limited by small sample sizes. We aimed to re-analyze publicly available fecal microbiota data from IBD patients. Methods: We extracted original fecal 16S rRNA amplicon sequencing data from 45 cohorts of IBD patients and healthy individuals using the BioProject database at the National Center for Biotechnology Information. Unlike previous meta-analyses, we merged all study cohorts into a single dataset, including sex, age, geography, and disease information, based on which microbiota signatures were analyzed, while accounting for varying technical platforms. Results: Among 2518 individuals in the combined dataset, we discovered a hitherto unseen number of genera associated with IBD. A total of 77 genera associated with CD, of which 38 were novel associations, and a total of 64 genera associated with UC, of which 28 represented novel associations. Signatures were robust across different technical platforms and geographic locations. Reduced alpha diversity in IBD compared to healthy individuals, in CD compared to UC, and altered microbiota composition (beta diversity) in UC and especially in CD as compared to healthy individuals were found. Conclusions: Combining original microbiota data from 45 cohorts, we identified a hitherto unseen large number of genera associated with IBD. Identification of microbiota features robustly associated with CD and UC may pave the way for the identification of new treatment targets.",
keywords = "16S rRNA amplicon sequencing, Crohn's disease, Faecalibacterium, IBD, Lachnospiraceae NK4A136 group, microbiome, microbiota, Roseburia, Turicibacter, ulcerative colitis",
author = "Vestergaard, {Marie Vibeke} and Allin, {Kristine H.} and Carsten Eriksen and Oliwia Zakerska-Banaszak and Arasaradnam, {Ramesh P.} and Alam, {Mohammad T.} and Karsten Kristiansen and Susanne Brix and Tine Jess",
note = "Publisher Copyright: {\textcopyright} 2023 The Authors. United European Gastroenterology Journal published by Wiley Periodicals LLC on behalf of United European Gastroenterology.",
year = "2024",
doi = "10.1002/ueg2.12485",
language = "English",
volume = "12",
pages = "22--33",
journal = "United European Gastroenterology Journal",
issn = "2050-6406",
publisher = "SAGE Publications",
number = "1",

}

RIS

TY - JOUR

T1 - Gut microbiota signatures in inflammatory bowel disease

AU - Vestergaard, Marie Vibeke

AU - Allin, Kristine H.

AU - Eriksen, Carsten

AU - Zakerska-Banaszak, Oliwia

AU - Arasaradnam, Ramesh P.

AU - Alam, Mohammad T.

AU - Kristiansen, Karsten

AU - Brix, Susanne

AU - Jess, Tine

N1 - Publisher Copyright: © 2023 The Authors. United European Gastroenterology Journal published by Wiley Periodicals LLC on behalf of United European Gastroenterology.

PY - 2024

Y1 - 2024

N2 - Background: Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), affect millions of people worldwide with increasing incidence. Objectives: Several studies have shown a link between gut microbiota composition and IBD, but results are often limited by small sample sizes. We aimed to re-analyze publicly available fecal microbiota data from IBD patients. Methods: We extracted original fecal 16S rRNA amplicon sequencing data from 45 cohorts of IBD patients and healthy individuals using the BioProject database at the National Center for Biotechnology Information. Unlike previous meta-analyses, we merged all study cohorts into a single dataset, including sex, age, geography, and disease information, based on which microbiota signatures were analyzed, while accounting for varying technical platforms. Results: Among 2518 individuals in the combined dataset, we discovered a hitherto unseen number of genera associated with IBD. A total of 77 genera associated with CD, of which 38 were novel associations, and a total of 64 genera associated with UC, of which 28 represented novel associations. Signatures were robust across different technical platforms and geographic locations. Reduced alpha diversity in IBD compared to healthy individuals, in CD compared to UC, and altered microbiota composition (beta diversity) in UC and especially in CD as compared to healthy individuals were found. Conclusions: Combining original microbiota data from 45 cohorts, we identified a hitherto unseen large number of genera associated with IBD. Identification of microbiota features robustly associated with CD and UC may pave the way for the identification of new treatment targets.

AB - Background: Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), affect millions of people worldwide with increasing incidence. Objectives: Several studies have shown a link between gut microbiota composition and IBD, but results are often limited by small sample sizes. We aimed to re-analyze publicly available fecal microbiota data from IBD patients. Methods: We extracted original fecal 16S rRNA amplicon sequencing data from 45 cohorts of IBD patients and healthy individuals using the BioProject database at the National Center for Biotechnology Information. Unlike previous meta-analyses, we merged all study cohorts into a single dataset, including sex, age, geography, and disease information, based on which microbiota signatures were analyzed, while accounting for varying technical platforms. Results: Among 2518 individuals in the combined dataset, we discovered a hitherto unseen number of genera associated with IBD. A total of 77 genera associated with CD, of which 38 were novel associations, and a total of 64 genera associated with UC, of which 28 represented novel associations. Signatures were robust across different technical platforms and geographic locations. Reduced alpha diversity in IBD compared to healthy individuals, in CD compared to UC, and altered microbiota composition (beta diversity) in UC and especially in CD as compared to healthy individuals were found. Conclusions: Combining original microbiota data from 45 cohorts, we identified a hitherto unseen large number of genera associated with IBD. Identification of microbiota features robustly associated with CD and UC may pave the way for the identification of new treatment targets.

KW - 16S rRNA amplicon sequencing

KW - Crohn's disease

KW - Faecalibacterium

KW - IBD

KW - Lachnospiraceae NK4A136 group

KW - microbiome

KW - microbiota

KW - Roseburia

KW - Turicibacter

KW - ulcerative colitis

U2 - 10.1002/ueg2.12485

DO - 10.1002/ueg2.12485

M3 - Journal article

C2 - 38041519

AN - SCOPUS:85178425963

VL - 12

SP - 22

EP - 33

JO - United European Gastroenterology Journal

JF - United European Gastroenterology Journal

SN - 2050-6406

IS - 1

ER -

ID: 375724018